• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease.川崎病冠状动脉病变的相关危险因素
Korean Circ J. 2018 Apr;48(4):329-331. doi: 10.4070/kcj.2018.0077.
2
Risk of coronary artery involvement in Kawasaki disease.川崎病冠状动脉受累的风险。
Arch Argent Pediatr. 2016 Apr;114(2):107-13. doi: 10.5546/aap.2016.eng.107. Epub 2016 Feb 5.
3
Prevalence and predictors of coronary artery disease in adults with Kawasaki disease.川崎病成年患者冠状动脉疾病的患病率及预测因素
Cardiol Young. 2015 Aug;25(6):1124-9. doi: 10.1017/S1047951114001759. Epub 2014 Oct 23.
4
Severe triple vessel coronary artery disease and aneurysms in a young white man: disease progression of childhood Kawasaki disease.一名年轻白人男性的严重三支冠状动脉疾病和动脉瘤：儿童川崎病的疾病进展
J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):170-3. doi: 10.2459/JCM.0b013e32831b6de2.
5
Can Coronary Artery Involvement in Kawasaki Disease be Predicted?川崎病冠状动脉受累能否预测？
Diagnostics (Basel). 2013 Mar 26;3(2):232-43. doi: 10.3390/diagnostics3020232.
6
National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.美国川崎病和冠状动脉瘤导致的儿科住院情况全国调查。
Clin Rheumatol. 2017 Feb;36(2):413-419. doi: 10.1007/s10067-016-3512-6. Epub 2016 Dec 16.
7
Platelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease.血小板内皮细胞黏附分子-1基因多态性与川崎病慢性期冠状动脉病变相关。
Acta Cardiol Sin. 2017 May;33(3):273-284. doi: 10.6515/acs20161010a.
8
New coronary aneurysm formation and malapposition after zotarolimus-eluting stent implantation in Kawasaki disease.川崎病患者植入佐他莫司洗脱支架后新的冠状动脉瘤形成及贴壁不良
J Cardiol Cases. 2013 Aug 7;8(3):118-120. doi: 10.1016/j.jccase.2013.06.004. eCollection 2013 Sep.
9
Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.丹麦儿童川崎病临床特征评估及冠状动脉异常危险因素分析。
Acta Paediatr. 2013 Apr;102(4):385-90. doi: 10.1111/apa.12142. Epub 2013 Jan 21.
10
[Histopathological studies of endomyocardial biopsy on the children with Kawasaki disease].川崎病患儿心内膜心肌活检的组织病理学研究
Kokyu To Junkan. 1989 Apr;37(4):429-33.

引用本文的文献

1
[Multisystem inflammatory syndrome in children in the context of coronavirus disease 2019 pandemic].[2019冠状病毒病大流行背景下的儿童多系统炎症综合征]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jan 15;26(1):98-102. doi: 10.7499/j.issn.1008-8830.2306093.
2
A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.川崎病静脉注射免疫球蛋白抵抗和冠状动脉受累预测的决策树模型。
BMC Pediatr. 2022 Aug 5;22(1):474. doi: 10.1186/s12887-022-03533-6.
3
Delta-neutrophil index: a potential predictor of coronary artery involvement in Kawasaki disease by retrospective analysis.Delta-中性粒细胞指数：通过回顾性分析预测川崎病冠状动脉受累的潜在指标。
Rheumatol Int. 2019 Nov;39(11):1955-1960. doi: 10.1007/s00296-019-04448-9. Epub 2019 Sep 23.
4
Comparison of Clinical Symptoms and Cardiac Lesions in Children with Typical and Atypical Kawasaki Disease.典型与非典型川崎病患儿临床症状及心脏病变的比较
Med Sci (Basel). 2019 Apr 18;7(4):63. doi: 10.3390/medsci7040063.
5
Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?英夫利昔单抗，它真的是川崎病治疗的新曙光吗？
Korean Circ J. 2019 Feb;49(2):192-193. doi: 10.4070/kcj.2018.0460.

本文引用的文献

1
Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.根据冠状动脉转归情况分析不完全川崎病的实验室指标
Korean Circ J. 2018 Apr;48(4):287-295. doi: 10.4070/kcj.2017.0342.
2
The Harada score in the US population of children with Kawasaki disease.美国川崎病患儿群体中的原田评分。
Hosp Pediatr. 2014 Jul;4(4):233-8. doi: 10.1542/hpeds.2014-0008.
3
Complete and incomplete Kawasaki disease: two sides of the same coin.川崎病完全型与不完全型：同一疾病的两种表现。
Eur J Pediatr. 2012 Apr;171(4):657-62. doi: 10.1007/s00431-011-1631-2. Epub 2011 Dec 3.
4
Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.川崎病：静脉注射免疫球蛋白的病因发病机制和治疗作用。
Autoimmun Rev. 2010 Apr;9(6):441-8. doi: 10.1016/j.autrev.2009.12.004. Epub 2010 Jan 13.
5
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理：美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
6
Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease.白细胞和循环内皮细胞中诱导型一氧化氮合酶（iNOS）表达增强与急性川崎病冠状动脉病变的进展相关。
Pediatr Res. 2004 Apr;55(4):688-94. doi: 10.1203/01.PDR.0000113464.93042.A4. Epub 2004 Feb 5.

Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease.

作者信息

Kim Soo Jin

机构信息

Department of Pediatrics, Konkuk University School of Medicine, Seoul, Korea.

出版信息

Korean Circ J. 2018 Apr;48(4):329-331. doi: 10.4070/kcj.2018.0077.

DOI:10.4070/kcj.2018.0077
PMID:29625516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5889983/
Abstract
摘要